Submit a utility to the registry.

Filter results using search terms, or by selecting one or more valuation, condition, or population.

Viewing 1 - 10 of 44 results
Title   Year(s) of data collection   Valuation Method   Country   Condition  
Selection of autoimmune disease health state utilities (Schreiber S et al., J Crohns Colitis. 2023. doi:10.1093/ecco-jcc/jjad018) 2017 - 2018 EQ-5D Argentina, Australia, Belgium, Bulgaria, Canada, Croatia, Czechia, France, Georgia, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Korea (Republic of), Malaysia, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan (Province of China), Ukraine, United Kingdom of Great Britain and Northern Ireland, United States of America Ulcerative colitis
DOI
10.7910/DVN/XTLOGB
Author(s)
Registry, Utilities
Description
Health state utilities for autoimmune disease conditions
Sample Characteristics
An RCT for filgotinib in 786 adults with moderately to severely active UC
Title
Selection of neurological disease health state utilities (Gebrehiwet P et al., J Med Econ. 2023. doi:10.1080/13696998.2023.2192588)
Year(s) of data collection
2017 - 2019
Valuation Method
EQ-5D-5L
Country
Australia, Canada, Ireland, Netherlands, Spain, United States of America
Condition
Amyotrophic lateral sclerosis
DOI
10.7910/DVN/VJSSSX
Author(s)
Registry, Utilities
Description
Health state utilities for neurological disease conditions
Sample Characteristics
456 participants with clinical trial data from FORTITUDE-ALS that evaluated reldesemtiv versus placebo in patients with ALS
Title
Selection of oncology health state utilities (Yang M et al., Value Health. 2023. doi:10.1016/j.jval.2023.02.00)
Year(s) of data collection
2016 - 2021
Valuation Method
EQ-5D-5L
Country
Austria, Belgium, China, France, Germany, Israel, Italy, Japan, Korea (Republic of), Netherlands, Poland, Spain, Switzerland, Taiwan (Province of China), United States of America
Condition
Lung cancer
DOI
10.7910/DVN/L4V2LU
Author(s)
Registry, Utilities
Description
Health state utilities for oncology conditions
Sample Characteristics
273 patients with non-small cell lung cancer harboring MET exon 14 skipping treated with tepotinib
Title
Selection of autoimmune disease health state utilities (Saccà F et al., J Neurol. 2023. doi:10.1007/s00415-022-11517-w)
Year(s) of data collection
2018 - 2020
Valuation Method
EQ-5D-5L
Country
Belgium, Canada, Czechia, Denmark, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Serbia, United Kingdom of Great Britain and Northern Ireland, United States of America
Condition
Myasthenia gravis
DOI
10.7910/DVN/XTLOGB
Author(s)
Registry, Utilities
Description
Health state utilities for autoimmune disease conditions
Sample Characteristics
167 participants in phase 3 RCT of efgartigimod, ADAPT trial
Title
Selection of autoimmune disease health state utilities (Dewilde S et al., Adv Ther. 2023. doi:10.1007/s12325-023-02437-w)
Year(s) of data collection
2021
Valuation Method
EQ-5D-5L, HUI3
Country
Belgium, Canada, Denmark, France, Germany, Italy, Japan, Netherlands, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America
Condition
Myasthenia gravis
DOI
10.7910/DVN/XTLOGB
Author(s)
Registry, Utilities
Description
Health state utilities for autoimmune disease conditions
Sample Characteristics
9000 participants in the general population norms study that included adult patients with gMG randomly assigned to treatment with efgartigimod or conventional therapy
Title
Selection of COVID-19 health state utilities (Rosa RG et al., Intensive Care Med. 2023. doi:10.1007/s00134-022-06953-1)
Year(s) of data collection
2020 - 2022
Valuation Method
EQ-5D-3L
Country
Brazil
Condition
COVID-19
DOI
10.7910/DVN/MJ4J77
Author(s)
Registry, Utilities
Description
Health state utilities for states related to COVID-19
Sample Characteristics
1156 adults post-hospitalization COVID-19 patients
Title
Selection of mental health health state utilities (Adu MK et al., Brain Sci. 2023. doi:10.3390/brainsci13020293)
Year(s) of data collection
2020 - 2022
Valuation Method
EQ-5D-5L
Country
Canada
Condition
Depression
DOI
10.7910/DVN/QNA5ZF
Author(s)
Registry, Utilities
Description
Health state utilities for mental health conditions
Sample Characteristics
78 participants in the patient-centered randomized controlled pilot trial investigating combining repetitive transcranial magnetic stimulation with internet-delivered cognitive behavior therapy for the treatment of resistant depression
Title
Selection of autoimmune disease health state utilities (Dewilde S et al., Adv Ther. 2023. doi:10.1007/s12325-023-02437-w)
Year(s) of data collection
2019 - 2022
Valuation Method
EQ-5D-5L, HUI3
Country
Canada, Denmark, France, Germany, Italy, Japan, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America
Condition
Myasthenia gravis
DOI
10.7910/DVN/XTLOGB
Author(s)
Registry, Utilities
Description
Health state utilities for autoimmune disease conditions
Sample Characteristics
1299 participants (EQ-5D-5L) and 549 participants (HUI3) from MyRealWorld-MG study
Title
Selection of general population health health state utilities (Xie S et al., Eur J Health Econ. 2023. doi:10.1007/s10198-023-01566-x)
Year(s) of data collection
2019
Valuation Method
EQ-5D-5L, SF-6Dv2
Country
China
Condition
General population health
DOI
10.7910/DVN/OE5E2K
Author(s)
Registry, Utilities
Description
Health state utilities for general population health conditions
Sample Characteristics
3320 participants from the Chinese general population
Title
Selection of general population health health state utilities (Zhang W et al., Haemophilia. 2022. doi:10.1111/hae.14615)
Year(s) of data collection
2021
Valuation Method
SF-6Dv2
Country
China
Condition
General population health, Haemophilia
DOI
10.7910/DVN/OE5E2K
Author(s)
Registry, Utilities
Description
Health state utilities for general population health conditions
Sample Characteristics
206 age and gender matched sample of the general population with people with haemophilia